Clinical Trial Update: Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

View source ↗

Summary

Takeda-sponsored clinical trial evaluating brigatinib for non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Brigatinib (brigatinib)

Snippet

Sponsor: Takeda | Conditions: Non-small Cell Lung Cancer (NSCLC) | Status: RECRUITING